Precision requirements in stereotactic arrhythmia radioablation for ventricular tachycardia
- PMID: 38026083
- PMCID: PMC10679852
- DOI: 10.1016/j.phro.2023.100508
Precision requirements in stereotactic arrhythmia radioablation for ventricular tachycardia
Conflict of interest statement
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Participation in the “Standardized Treatment and Outcome Platform for Stereotactic Therapy Of Re-entrant tachycardia by a Multidisciplinary (STOPSTORM) Consortium", that has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 945119, is reported by Martin Fast, Judit Boda-Heggemann, Stephanie Tanadini-Lang, and Oliver Blanck. Dr. Boda-Heggemann reports personal fees from EBAMed SA and AstraZeneca and grants from Elekta AB outside of the submitted work. Dr. Tanadini-Lang declares that the University Hospital Zurich has research and teaching agreements with Siemens Healthineers. The husband of Dr. Tanadini-Lang is an employee of Siemens Healthineers. The remaining authors declare no Conflicts of Interest.
References
-
- Guckenberger M., Andratschke N., Dieckmann K., Hoogeman M.S., Hoyer M., Hurkmans C., et al. ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer. Radiother Oncol. 2017;124:11–17. doi: 10.1016/j.radonc.2017.05.012. - DOI - PubMed
-
- Guckenberger M., Baus W.W., Blanck O., Combs S.E., Debus J., Engenhart-Cabillic R., et al. Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery. Strahlenther Onkol. 2020;196:417–420. doi: 10.1007/s00066-020-01603-1. - DOI - PMC - PubMed
-
- Rieber J., Abbassi-Senger N., Adebahr S., Andratschke N., Blanck O., Duma M., et al. Influence of institutional experience and technological advances on outcome of stereotactic body radiation therapy for oligometastatic lung disease. Int J Radiat Oncol Biol Phys. 2017;98:511–520. doi: 10.1016/j.ijrobp.2016.09.026. - DOI - PubMed
-
- Andratschke N., Alheid H., Allgäuer M., Becker G., Blanck O., Boda-Heggemann J., et al. The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases. BMC Cancer. 2018;18:283. doi: 10.1186/s12885-018-4191-2. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources